Literature DB >> 32024824

Estimating growth patterns and driver effects in tumor evolution from individual samples.

Leonidas Salichos1,2, William Meyerson1,2, Jonathan Warrell1,2, Mark Gerstein3,4,5,6.   

Abstract

Tumors accumulate thousands of mutations, and sequencing them has given rise to methods for finding cancer drivers via mutational recurrence. However, these methods require large cohorts and underperform for low recurrence. Recently, ultra-deep sequencing has enabled accurate measurement of VAFs (variant-allele frequencies) for mutations, allowing the determination of evolutionary trajectories. Here, based solely on the VAF spectrum for an individual sample, we report on a method that identifies drivers and quantifies tumor growth. Drivers introduce perturbations into the spectrum, and our method uses the frequency of hitchhiking mutations preceding a driver to measure this. As validation, we use simulation models and 993 tumors from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium with previously identified drivers. Then we apply our method to an ultra-deep sequenced acute myeloid leukemia (AML) tumor and identify known cancer genes and additional driver candidates. In summary, our framework presents opportunities for personalized driver diagnosis using sequencing data from a single individual.

Entities:  

Mesh:

Year:  2020        PMID: 32024824      PMCID: PMC7002450          DOI: 10.1038/s41467-020-14407-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  54 in total

1.  Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.

Authors:  Jared J Gartner; Stephen C J Parker; Todd D Prickett; Ken Dutton-Regester; Michael L Stitzel; Jimmy C Lin; Sean Davis; Vijaya L Simhadri; Sujata Jha; Nobuko Katagiri; Valer Gotea; Jamie K Teer; Xiaomu Wei; Mario A Morken; Umesh K Bhanot; Guo Chen; Laura L Elnitski; Michael A Davies; Jeffrey E Gershenwald; Hannah Carter; Rachel Karchin; William Robinson; Steven Robinson; Steven A Rosenberg; Francis S Collins; Giovanni Parmigiani; Anton A Komar; Chava Kimchi-Sarfaty; Nicholas K Hayward; Elliott H Margulies; Yardena Samuels
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

2.  Synonymous mutations frequently act as driver mutations in human cancers.

Authors:  Fran Supek; Belén Miñana; Juan Valcárcel; Toni Gabaldón; Ben Lehner
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

3.  Intron retention is a widespread mechanism of tumor-suppressor inactivation.

Authors:  Hyunchul Jung; Donghoon Lee; Jongkeun Lee; Donghyun Park; Yeon Jeong Kim; Woong-Yang Park; Dongwan Hong; Peter J Park; Eunjung Lee
Journal:  Nat Genet       Date:  2015-10-05       Impact factor: 38.330

4.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing.

Authors:  Peter J Campbell; Erin D Pleasance; Philip J Stephens; Ed Dicks; Richard Rance; Ian Goodhead; George A Follows; Anthony R Green; P Andy Futreal; Michael R Stratton
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

Review 5.  The promise and reality of personal genomics.

Authors:  Bryndis Yngvadottir; Daniel G Macarthur; Hanjun Jin; Chris Tyler-Smith
Journal:  Genome Biol       Date:  2009-09-02       Impact factor: 13.583

6.  Characterization of brain cancer stem cells: a mathematical approach.

Authors:  C Turner; A R Stinchcombe; M Kohandel; S Singh; S Sivaloganathan
Journal:  Cell Prolif       Date:  2009-06-23       Impact factor: 6.831

7.  MuSiC: identifying mutational significance in cancer genomes.

Authors:  Nathan D Dees; Qunyuan Zhang; Cyriac Kandoth; Michael C Wendl; William Schierding; Daniel C Koboldt; Thomas B Mooney; Matthew B Callaway; David Dooling; Elaine R Mardis; Richard K Wilson; Li Ding
Journal:  Genome Res       Date:  2012-07-03       Impact factor: 9.043

8.  A Multi-stage Representation of Cell Proliferation as a Markov Process.

Authors:  Christian A Yates; Matthew J Ford; Richard L Mort
Journal:  Bull Math Biol       Date:  2017-10-13       Impact factor: 1.758

9.  Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.

Authors:  Thomas J Mitchell; Samra Turajlic; Andrew Rowan; David Nicol; James H R Farmery; Tim O'Brien; Inigo Martincorena; Patrick Tarpey; Nicos Angelopoulos; Lucy R Yates; Adam P Butler; Keiran Raine; Grant D Stewart; Ben Challacombe; Archana Fernando; Jose I Lopez; Steve Hazell; Ashish Chandra; Simon Chowdhury; Sarah Rudman; Aspasia Soultati; Gordon Stamp; Nicos Fotiadis; Lisa Pickering; Lewis Au; Lavinia Spain; Joanna Lynch; Mark Stares; Jon Teague; Francesco Maura; David C Wedge; Stuart Horswell; Tim Chambers; Kevin Litchfield; Hang Xu; Aengus Stewart; Reza Elaidi; Stéphane Oudard; Nicholas McGranahan; Istvan Csabai; Martin Gore; P Andrew Futreal; James Larkin; Andy G Lynch; Zoltan Szallasi; Charles Swanton; Peter J Campbell
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

10.  A stochastic model for immunotherapy of cancer.

Authors:  Martina Baar; Loren Coquille; Hannah Mayer; Michael Hölzel; Meri Rogava; Thomas Tüting; Anton Bovier
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

View more
  6 in total

1.  Inferring ongoing cancer evolution from single tumour biopsies using synthetic supervised learning.

Authors:  Tom W Ouellette; Philip Awadalla
Journal:  PLoS Comput Biol       Date:  2022-04-28       Impact factor: 4.779

Review 2.  Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments.

Authors:  Beatrice Aramini; Valentina Masciale; Chiara Arienti; Massimo Dominici; Franco Stella; Giovanni Martinelli; Francesco Fabbri
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

3.  Integrative analysis of genomic and transcriptomic data of normal, tumour, and co-occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour initiation and progression.

Authors:  Arnab Ghosh; Chitrarpita Das; Sandip Ghose; Arindam Maitra; Bidyut Roy; Partha P Majumder; Nidhan K Biswas
Journal:  J Pathol       Date:  2022-04-21       Impact factor: 9.883

4.  Clonal fitness inferred from time-series modelling of single-cell cancer genomes.

Authors:  Sohrab Salehi; Farhia Kabeer; Nicholas Ceglia; Mirela Andronescu; Marc J Williams; Kieran R Campbell; Tehmina Masud; Beixi Wang; Justina Biele; Jazmine Brimhall; David Gee; Hakwoo Lee; Jerome Ting; Allen W Zhang; Hoa Tran; Ciara O'Flanagan; Fatemeh Dorri; Nicole Rusk; Teresa Ruiz de Algara; So Ra Lee; Brian Yu Chieh Cheng; Peter Eirew; Takako Kono; Jenifer Pham; Diljot Grewal; Daniel Lai; Richard Moore; Andrew J Mungall; Marco A Marra; Andrew McPherson; Alexandre Bouchard-Côté; Samuel Aparicio; Sohrab P Shah
Journal:  Nature       Date:  2021-06-23       Impact factor: 49.962

Review 5.  New Insights into Therapy-Induced Progression of Cancer.

Authors:  Polina V Shnaider; Olga M Ivanova; Irina K Malyants; Ksenia S Anufrieva; Ilya A Semenov; Marat S Pavlyukov; Maria A Lagarkova; Vadim M Govorun; Victoria O Shender
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

6.  Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas.

Authors:  Eve Kazarian; Asher Marks; Jin Cui; Armine Darbinyan; Elizabeth Tong; Sabine Mueller; Soonmee Cha; Mariam S Aboian
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.